Study Focus:

Artemis, a prospective, cluster-randomized study, is designed to evaluate whether patient copayment reduction significantly influences antiplatelet therapy selection and long-term adherence, as well as patient outcomes and overall cost of care after heart attack.

Study Population:
Approximately 300 U.S. hospitals enrolling approximately 11,000 heart attack patients.